SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-4/A - Registration of securities, business combinations: [Amend]
SEC Accession No. 0001104659-20-118623
Filing Date
2020-10-28
Accepted
2020-10-27 18:02:32
Documents
12

Document Format Files

Seq Description Document Type Size
1 S-4/A tm2023267-11_s4a.htm S-4/A 7675730
2 GRAPHIC lg_neurotrope-4c.jpg GRAPHIC 187232
3 GRAPHIC lg_metuchen-4clr.jpg GRAPHIC 397025
4 GRAPHIC tm2023267d3-fc_organ4c.jpg GRAPHIC 63345
5 GRAPHIC tm2023267d3-fc_org2.jpg GRAPHIC 1434337
6 GRAPHIC tm2022154d1-fc_therap4clr.jpg GRAPHIC 1512885
7 GRAPHIC tm2022154d1-fc_pkce4clr.jpg GRAPHIC 1993697
8 GRAPHIC tm2022154d1-fc_bryost4clr.jpg GRAPHIC 2984737
9 GRAPHIC tm2022154d1-fc_dhabwlr.jpg GRAPHIC 586822
10 GRAPHIC tm2022154d1-bc_coverage4clr.jpg GRAPHIC 1175491
11 GRAPHIC tm2022154d1-lc_overall4clr.jpg GRAPHIC 2532718
12 GRAPHIC lg_gemini-4clr.jpg GRAPHIC 158276
  Complete submission text file 0001104659-20-118623.txt   25389623
Mailing Address 5301 WISCONSIN AVENUE NW SUITE 570 WASHINGTON DC 20015
Business Address 5301 WISCONSIN AVENUE NW SUITE 570 WASHINGTON DC 20015 301-215-7440
Petros Pharmaceuticals, Inc. (Filer) CIK: 0001815903 (see all company filings)

IRS No.: 851410058 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-4/A | Act: 33 | File No.: 333-240064 | Film No.: 201265402
SIC: 2834 Pharmaceutical Preparations